TET3调控OGFR-AS1 5hmC在激素性股骨头坏死骨微血管内皮细胞凋亡中的机制研究
批准号:
82060412
项目类别:
地区科学基金项目
资助金额:
33.0 万元
负责人:
白志刚
依托单位:
学科分类:
骨、关节、软组织运动损伤
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
白志刚
中文摘要
骨微血管内皮细胞(BMECs)构成的骨内微血管内衬损伤是激素性股骨头坏死(SONFH)启动的关键因素,但机制未清。5-羟甲基胞嘧啶(5hmC)富集作为长久动态的表观遗传标记在调控基因表达中起重要作用。同时lncRNA可通过多种途径和方式参与基因表达调控,且预实验结果提示其参与了BMECs凋亡的调节,故推测:5hmC富集调控特异性lncRNA引起BMECs凋亡是SONFH发生的重要机制。为了验证该假说,筛选并确定OGFR-AS1是SONFH发生的特异性lncRNA;构建其及功能性靶基因PDK2腺病毒载体并转染细胞,地塞米松干预后分析BMECs凋亡情况,明确OGFR-AS1和PDK2在SONFH中的作用;观察5hmC富集在SONFH中的变化,并确定TET3为关键调控因子;探讨TET3调控OGFR-AS1启动子区5hmC动态修饰介导PDK2表达的机制,探寻关键靶点,为防治SONFH提供理论依据。
英文摘要
Bone microvascular endothelial cells (BMECs) constitute the intraosseous microvascular lining injury is a key factor for the initiation of steroid-induced osteonecrosis of femoral head (SONFH), but the mechanism is unclear. 5-Hydroxymethylcytosine (5hmC) enrichment as a long-term dynamic epigenetic marker plays an important role in regulating gene expression. Meanwhile, lncRNA can regulate gene expression in various approach and methodology, and preliminary results suggest that it participates in the regulation of BMECs apoptosis. Therefore, it is speculated that 5hmC enrichment regulates the specific lncRNA leading to apoptosis of BMECs, which is an important mechanism for the occurrence of SONFH. In order to verify this hypothesis, screen and validate that OGFR-AS1 is a specific lncRNA that occurs in SONFH. Construct the adenoviral vector of OGFR-AS1 and its functional target gene PDK2 to transfect the cells. After dexamethasone intervention, analyze the apoptosis of BMECs to clarify the role of OGFR-AS1 and PDK2 in SONFH. Observe the change of 5hmC enrichment in SONFH and determine TET3 as a key regulator. To explore the mechanism of TET3 regulating the 5hmC dynamic modification of OGFR-AS1 promoter to mediate PDK2 expression and explore key targets, which provide a theoretical basis for the prevention and treatment of SONFH.
激素性股骨头坏死(Steroid-induced osteonecrosis of femoral head,SONFH)是一种重大常见病、多发病、致残率高,影响治疗效果的因素主有贻诊和晚期治疗。非编码RNA(ncRNA)通过染色质重塑、mRNA降解和翻译抑制等参与疾病调控,具有类型多、作用模式多和数量多等“三多”和可逆性、可预见性和可遗传性等特点,因此针对ncRNA靶向研究成为焦点。如以ncRNA为靶标,深入阐明ncRNA和相关蛋白功能网络与调控机制,对推动以ncRNA为靶点的SONFH的基因诊断与治疗有重要意义。本项目深入研究了糖皮质激素引发的SONFH的分子机制,并探索了潜在的生物标记物和治疗靶点。通过高通量RNA测序技术,我们筛选并鉴定了多种与Dex诱导的SONFH显著相关的特异性非编码RNA(如ENSMUST00000162697、NR_015473.1等),并通过生物信息学分析揭示了它们在关键信号通路中的作用。我们还重点探讨了TET3调控OGFR-AS1与5hmC修饰在骨微血管内皮细胞凋亡中的作用,发现TET3通过上调OGFR-AS1,促进细胞凋亡,提示其作为SONFH防治的潜在靶点。同时,研究表明lncRNA H19在Dex诱导的成骨细胞凋亡中发挥重要作用,能够通过调控MAPK/ERK信号通路和FoxO1活性抑制细胞凋亡,可能成为治疗SONFH的一个新方向。此外,我们还发现lncRNA XR_877193.1在Dex诱导的MC3T3-E1细胞中上调,并通过调控PI3K/AKT信号通路促进铁死亡。综上所述,本研究从ncRNA与蛋白质的相互作用入手,全面系统地解析以ncRNA为纽带的蛋白质功能网络对SONFH的作用。本项目已发表论文5篇,其中SCI 2篇,中文核心3篇;申请发明专利3项;培养硕士研究生2人。
国内基金
海外基金